EUVIMEDEUVIMED entdecken
LeserbriefRandomisierte kontrollierte Studie

Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”

Christopher E Millis iD, Denise F Feradov, Xavier E Prida

Circulation · 2024

DOI: 10.1161/circulationaha.123.067571 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Circulation, 2024. Verfasst von Christopher E Millis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (C.E.M.), University of South Florida Morsani College of Medicine, Tampa. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Vitamin K, Frail Elderly. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsVitamin KFrail ElderlyHumansAgedAdministration, OralRandomized Controlled Trials as TopicDrug SubstitutionAged, 80 and over

Substanzen

AnticoagulantsVitamin K

Autor:innen und Institutionen

  • Department of Internal Medicine (C.E.M.), University of South Florida Morsani College of Medicine, Tampa.
  • Division of Cardiovascular Sciences (D.F.F., X.E.P.), University of South Florida Morsani College of Medicine, Tampa.

ORCID-Profile: Christopher E Millis

Zitieren

APA

Millis, C. E., Feradov, D. F., & Prida, X. E. (2024). Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. https://doi.org/10.1161/circulationaha.123.067571

Vancouver

Millis CE, Feradov DF, Prida XE. Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. 2024. doi:10.1161/circulationaha.123.067571

BibTeX
@article{Millis2024,
  author = {Millis, Christopher E and Feradov, Denise F and Prida, Xavier E},
  title = {Letter by Millis et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.123.067571}
}
Kostenlos starten →